Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 219M | 7M |
| Research and development | 315M | 295M |
| Selling, general and administrative | 63M | 39M |
| Operating expenses | 378M | 334M |
| Operating income | −159M | −327M |
| Net income | −114M | −274M |
| Earnings per share | −1.28 | −3.36 |
| Earnings per share, diluted | −1.28 | −3.36 |
| Weighted average shares | 88M | 82M |
| Weighted average shares, diluted | 88M | 82M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 158M | 113M | 299M | 115M | 130M | 84M | 400M | 183M |
| Short-term investments | 514M | 527M | 488M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −71M | −248M |
| Depreciation and amortisation | 3M | 2M |
| Share-based compensation | 46M | 35M |
| Capital expenditure | 2M | 4M |
| Investing cash flow | 70M | −503M |
| Financing cash flow | 30M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 555M |
| 563M |
| 592M |
| 520M |
| 519M |
| Receivables | — | — | — | — | — | 3,000 | 20,000 | 1,000 |
| Current assets | 696M | 667M | 803M | 686M | 708M | 690M | 932M | 713M |
| Property, plant and equipment | 9M | 8M | 8M | 9M | 9M | 9M | 8M | 7M |
| Total assets | 1.03B | 1.11B | 1.19B | 1.04B | 1.10B | 1.12B | 1.24B | 974M |
| Current liabilities | 65M | 59M | 65M | 55M | 51M | 46M | 41M | 41M |
| Total liabilities | 93M | 86M | 93M | 82M | 77M | 65M | 59M | 42M |
| Equity | 937M | 1.02B | 1.09B | 960M | 1.02B | 1.06B | 1.18B | 932M |
| Shares outstanding | 88M | 88M | 88M | 88M | 88M | 87M | 86M | 76M |
| Shares issued | 88M | 88M | 88M | 88M | 88M | 87M | 86M | 76M |
| 678M |